Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)Patrick Y. Wen(Dana-Farber Brigham Cancer Center), Michael D. Prados(UCSF Helen Diller Family Comprehensive Cancer Center)Neuro-OncologyMarch 17, 200910.1215/15228517-2009-010Cited by 161SaveCiteExport RISWatch citationsRelated PapersGlioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions|Neuro-Oncology|2020|1.1kPhase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02|Neuro-Oncology|2014|166